MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2023 International Congress

    The effect of botulinum toxin on anxiety in cervical dystonia.

    D. Sugar, R. Patel, C. Comella, D. Gonzalez, G. Gray, G. Stebbins, A. Mahajan (Chicago, USA)

    Objective: To assess the impact of botulinum toxin injections (BoNT) on anxiety symptoms and motor symptoms in cervical dystonia (CD) during one treatment cycle. Background:…
  • 2023 International Congress

    Ultra long-term outcome of deep brain stimulation (DBS) compared to botulinum toxin (BoNT) treatment in cervical dystonia (CD)

    IM. Wedding, V. Siewers, IM. Skogseid (Oslo, Norway)

    Objective: To compare residual symptoms and disease-specific quality of life (DS-QoL) in CD patients treated with DBS, or BoNT injections alone, for minimum 3 years.…
  • 2023 International Congress

    A Phase 2, Double-blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ABP-450 (PrabotulinumtoxinA) in Adults with Isolated Cervical Dystonia

    J. Jankovic, C. Oh, Y. Liu, C. Comella (Irvine, USA)

    Objective: To evaluate the safety and the efficacy of ABP-450 (prabotulinumtoxinA) in patients with cervical dystonia (CD). Background: ABP-450 (prabotulinumtoxinA) is a new 900kDA botulinumtoxinA.…
  • 2023 International Congress

    Impact of the COVID-19 pandemic in the long-term efficacy of botulinum toxin treatment

    F. Barros, C. Nunes, F. Magalhães, A. Mestre, C. Machado, D. Carneiro (Coimbra, Portugal)

    Objective: To analyse the impact of the COVID-19 pandemic in the long-term efficacy of treatment with botulinum toxin (BoT). Background: The COVID-19 pandemic brought new…
  • 2023 International Congress

    A retrospective comparison between EMG and US-guided botulinum injections for cervical dystonia

    V. Livneh, A. Socher, M. Cohen, Y. Schechter, I. Israel, T. Gurevic, G. Yahalom (Tel Aviv, Israel)

    Objective: To assess the efficacy and safety of ultrasound-guided (USg) botulinum toxin (BT) injections versus electromyography–guided (EMGg)- BT injections for cervical dystonia. Background: BT is…
  • 2023 International Congress

    Pisa syndrome and botulinum toxin injection in paraspinal muscles ipsilateral to the bending side: a pilot study

    V. Cenacchi, TMI. Lombardo, G. Bellavita, M. Catalan, V. Tommasini, M. Liccari, G. Mazzon, L. Antonutti, P. Manganotti (Trieste, Italy)

    Objective: Our study aimed at evaluating the clinical and electromyographical effects of botulinum toxin (BoNT) injections in patients with Pisa syndrome (PS) in Parkinson’s disease…
  • 2023 International Congress

    Use of the Dysphagia Handicap Index (DHI) patient reported outcomes measure in Parkinson disease and cervical dystonia

    A. Silbergleit (Birmingham, USA)

    Objective: Objective: To demonstrate the value of using the DHI in movement disorders clinics. Background: Background: Dysphagia has a negative effect on work, leisure, and…
  • 2023 International Congress

    Botulinum toxin treatment for focal dystonia in a Tunisian cohort

    M. Jamoussi, H. Benrhouma, M. Ben Hafsa, T. Ben Younes, Z. Miladi, H. Klaa, I. Kraoua, N. Gouider Khouja, I. Ben Youssef (Tunis, Tunisia)

    Objective: Our aim was to report the etiology, management and outcome of patients with focal dystonia. Background: Focal dystonia (FD) is characterized by involuntary muscle…
  • 2023 International Congress

    Patient characteristics and real-world use of botulinum toxins for treatment of cervical dystonia and blepharospasm

    M. Hast, A. Kong, S. Desai, S. Syed, J. Holmes (Raleigh, USA)

    Objective: To describe the characteristics of patients with cervical dystonia (CD) or blepharospasm (BLEPH) treated with botulinum toxin (BoNT) in routine care using claims data…
  • 2023 International Congress

    A case of idiopathic lower limb dystonia treated with combined use of botulinum toxin type A and phenol nerve block

    E. Bianchini, A. Massimiani, J. Bemporad, M. Giovannelli (Rome, Italy)

    Objective: Here we report a case of focal LLD successfully treated with combined botulinum neurotoxin type A (BoNTA) and Nerve block (NB). Background: Among focal dystonias,…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley